$NICE

NICE (NICE) Q2 2026 Earnings Call Transcript

NICE Ltd. reported Q2 2026 revenue of $782 million, up 8% year over year, and cloud revenue of $609 million, up 12.6%. Non-GAAP EPS was $2.70. Management cited CX AI and self-service ARR of $362 million (+52%), operating margin of 25.3%, and free cash flow of $93 million. Full-year 2026 revenue guidance is $3.170B to $3.190B.

Original reporting
Published Aug 12, 2026, 7:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 8:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NICE (NICE) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$NICEBullishHigh
01

Why it matters

The call provides a full set of fresh earnings datapoints: Q2 revenue/EPS, cloud and AI backlog growth, margin and cash flow context, and updated FY 2026 and Q3 2026 guidance ranges, plus a named large contract win (HMRC) and distribution expansion via system integrators.

02

Market read

Traders can update models immediately using the raised FY EPS guidance, Q3 guidance ranges, and the disclosed AI backlog and cloud backlog conversion narrative.

03

What to watch

Free cash flow was $93 million and influenced by working capital timing, so cash conversion may not immediately track earnings quality; also Q3 revenue guidance implies only mid-single-digit growth.

Relevance 9/10Novelty 9/10Timing: post-earnings, guidance for Q3 and full-year 2026

Background

NICE is transitioning toward a unified AI-native platform strategy centered on CXone and conversational AI (Cognigy), with emphasis on enterprise AI agent deployment and cloud migration.

Company-level read

Ticker impact

$NICEBullishMedium confidence
Context

NICE reported Q2 results and raised FY 2026 non-GAAP EPS guidance to $11.06 to $11.26, citing higher operating margins and AI-driven cloud growth.

Expected impact

Likely bullish bias for the next few sessions as traders price in the raised EPS range, with volatility around the Q3 revenue and adoption-lag commentary.

Evidence & confidence

The article discloses multiple fresh, decision-relevant datapoints: Q2 revenue/EPS prints, FY and Q3 guidance ranges, and a specific contract win (HMRC) alongside AI backlog growth. The main offset is management’s stated lag between bookings and customer adoption timing.

Market effects

Reinforces demand for AI-native contact center platforms and conversational AI integration, potentially supporting sentiment for CXaaS/CCaaS peers.

International growth acceleration (EMEA +30%, APAC +8%) highlights continued regional momentum for enterprise AI deployments.

Sovereign cloud availability in AWS Europe signals ongoing regulatory-driven procurement demand across highly regulated industries.

Counterpoint

Despite raised EPS guidance, services revenue declined 11% and management flagged a potential lag between bookings and customer adoption, which can pressure near-term revenue mix.

Key entities

  • NICE

    Provider of CXone and conversational AI (Cognigy), reporting Q2 2026 results and updated 2026 guidance.

  • HMRC

    Government customer referenced for a large CXone and Cognigy contract win (eight-digit ACV).

  • AWS European Sovereign Cloud

    Cloud deployment channel mentioned for making NICE AI solutions available to regulated organizations.

  • RingCentral

    Referenced in a multiyear agreement to resell RingCentral UCaaS while RingCentral continues to offer NICE CXone.

Related articles

$TEVAMed

Wed: Teva jumps but TASE continues to lose ground

Globes reports the Tel Aviv Stock Exchange fell on July 29, with the Tel Aviv 35 down 0.99% and Tel Aviv 125 down 0.96%. Teva Pharmaceutical (NYSE: TEVA; TASE: TEVA) rose 10.17% after Q2 results and raised revenue guidance. Other movers included Enlight Renewable Energy, Elbit Systems, and banks such as Bank Leumi and Hapoalim.

$NICEMed

NiCE Announces the Future of AI-Powered CX

NiCE (Nasdaq: NICE) announced that agentic AI is now native at the core of its customer experience platform, enabling enterprises to run AI agents, workflows, data, and systems as a single operating model. The company cited 66% year-over-year growth in first-quarter 2026 annual recurring revenue and said it was 14% of cloud revenue. It also highlighted enterprise security/compliance certifications and cited customer and analyst recognition.

$SOUNMedAI 8/10

SoundHound AI (NASDAQ: SOUN) Bets On Proprietary AI Models To Outpace NICE (NASDAQ: NICE) And Five9 (NASDAQ: FIVN)

SoundHound AI (SOUN) says it is shifting toward proprietary AI models to compete in conversational and agentic AI. It launched OASYS, which management says can create, orchestrate, evaluate and improve agents and cut deployment from months to minutes. SoundHound plans to use its Polaris speech model and internal LLMs to reduce reliance on costly third-party models. It reported Q1 2026 revenue of $44.2M (+52% YoY). The article notes SOUN trades at 16x forward P/S vs 13.48 industry average and has

$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).

$NBISMed

Nebius (NBIS) Soared 48% Last Week. Is It Time to Sell?

Nebius Group NV (NASDAQ:NBIS) shares rose 47.7% week over week after the company reported revenue up more than fivefold to $582.3M and beating analyst expectations of $572.75M. The firm also discussed expanding AI infrastructure, raising its year-end contracted power target to 5 GW and pricing targets of $40M to $50M per megawatt. Analysts issued mostly buy ratings with price targets raised; one cited a hold.